XML 61 R50.htm IDEA: XBRL DOCUMENT
v3.25.3

Long-Term Investments - Schedule of Extent the Investee Relies (Details) | 9 Months Ended
--- | ---
Sep. 30, 2025
Braingenesis Biotechnology Co., Ltd. [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | No specific business relationship
Genepharm Biotech Corporation [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | No specific business relationship
BioHopeKing Corporation [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | Collaborating with the Company to develop and commercialize drugs (referring to Note 4, Collaborative Agreements)
BioLite Japan K.K. [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | The Company’s joint venture noncontrolling subsidiary perform research and development activities and explore business opportunities in Japan
ForSeeCon Eye Corporation [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | Collaborating with the Company to develop and commercialize ophthalmic medical devices (referring to Note 4, Collaborative Agreements)
BioFirst Corporation [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | Loaned from the investee and provides research and development support service
OncoX BioPharma, Inc. [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | Collaborating with the Company to develop and commercialize single-herb botanical drug for treatment of certain diseases (referring to Note 4, Collaborative Agreements)
Rgene Corporation [Member] |
Schedule of Extent the Investee Relies [Line Items] |
The extent the investee relies on the Company for its business, description | Collaborating with the Company to develop and commercialize drugs (referring to Note 4, Collaborative Agreements)

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the major products or services that a subsidiary or equity investee sells or provides and its principal markets, including locations of those markets. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeNatureOfOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_GenepharmBiotechCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BioHopeKingCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BioLiteJapanKKMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_ForSeeConEyeCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_OncoXBioPharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=abvc_RgeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |